albuterol has been researched along with Arterial Occlusive Diseases in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kals, J | 1 |
| Kampus, P | 1 |
| Kals, M | 1 |
| Pulges, A | 1 |
| Teesalu, R | 1 |
| Zilmer, M | 1 |
1 other study available for albuterol and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease.
Topics: Adrenergic beta-Agonists; Albuterol; Aorta; Arterial Occlusive Diseases; Arteries; Blood Flow Veloci | 2006 |